Skip to main content
Caplight Logo









IbisVision

IbisVision

Private
GlasgowHealthcare & Life Scienceshttps://www.ibis.vision/

Last Round

Growth Equity

May 11, 2023

Total Funding Raised

$5.64M

Company Overview

IbisVision is a diagnostic equipment company that provides a cloud-based remote eye exam and vision testing platform for the optical industry.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Patient Engagement, Medical Devices, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

tele-optometryremote eye testingvirtual eye examdigital vision screeningprescription verificationtelemedicine platformhealthtechvertical SaaSremote triagepatient engagementSaaSusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IbisVision Comparables

Compare IbisVision with similar companies based on industry and business-model similarity.

IbisVision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
20/20NOW
83%
Smart Vision Labs
82%
Visibly
81%

IbisVision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityMay 11, 2023
VC RoundMar 31, 2022
VC RoundFeb 12, 2021
SeedJun 1, 2019
VC RoundMar 15, 2018
Grant
Feb 27, 2017

Key People

Founding team and executive leadership

Steve Ingram

Chief Operating Officer

Executive Team

IbisVision Investors

Notable investors and investment history

IbisVision investors
InvestorRounds
Scottish EDGEGrant
Apollo Informal InvestmentSeed
Innovate UKGrant
Compiler Venture CapitalVC Round, Growth Equity
Deepbridge CapitalSeed
Scottish Investment Bank (Scottish Enterprise)Grant, VC Round, Growth Equity, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors increased 1146% MoM, reaching 3.4K.

  • Nov 13, 2024

    Monthly visitors increased 61% MoM, reaching 1.1K.

IbisVision Filings

Explore SEC and related filing metadata, where available.

IbisVision filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about IbisVision's valuation, stock price, and market status.

Is IbisVision a public or private company?

IbisVision is a private company.

What is the current stock price of IbisVision?

IbisVision is a private company with no public stock price. Caplight tracks IbisVision's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is IbisVision worth (valuation)?

Valuation information for IbisVision is not publicly available.

Can I buy IbisVision stock?

IbisVision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was IbisVision's last funding round?

IbisVision's most recent funding round was Growth Equity on May 11, 2023.

Who are the main investors in IbisVision?

Key investors in IbisVision include Compiler Venture Capital.

Will IbisVision IPO soon?

No public IPO plans have been announced for IbisVision.

How can I track IbisVision secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IbisVision's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGlasgow
Employee Range10
Year Founded2014
Last FundingMay 11, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?